CLASS II ONGOING Device recall · Reported 17 May 2023 · FDA Enforcement Report

TDHisto/Cyto recalled by Technidata

Technidata is recalling TDHisto/Cyto - A, distributed nationwide in the US. The recall was initiated on 27 Mar 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI : 03770027519010 All TDHisto/Cyto software versions
Quantity recalled1 unit

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1573-2023
FDA event ID
92184
Recalling firm
Technidata, Montbonnot St Martin, N/A
Classification
Class II
Status
Ongoing
Recall initiated
27 Mar 2023
FDA classified
10 May 2023
Reported
17 May 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

27 Mar 2023Recall initiated by company
10 May 2023Classified by FDA+44 days
17 May 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

In a specific use case, when printing labels for slides, some labels may display wrong information

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

TDHisto/Cyto - A software product used for managing medical information in the field of laboratories performing histology, nongynecological and gynecological cytology and autopsy activities.

Where it was distributed

US Nationwide distribution in the state of CA.

Nationwide California

Questions about this recall

Is TDHisto/Cyto - A recalled?

Yes. Technidata recalled TDHisto/Cyto - A on 27 Mar 2023. The recall is Class II and its status is Ongoing. Recall number Z-1573-2023.

Why was it recalled?

In a specific use case, when printing labels for slides, some labels may display wrong information

Which lots are affected?

UDI-DI : 03770027519010 All TDHisto/Cyto software versions

Where was it sold?

US Nationwide distribution in the state of CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Technidata

All 4

Other Medical Software recalls

All 903